"Our Buyback Premium Portfolio is beating the S&P 500 by more than 65% since its inception in 2000; the portfolio is up 54.48% vs. a decline of 10.56% in the S&P 500 over the same time frame," notes buyback specialist David Fried.

The editor of The Buyback Letter explains, "Here's a look at three new additions to this portfolio: Forest Labs (FRX), Dollar Tree (DLTR) and Ryder System (R).

"Forest Labs is an international pharmaceutical manufacturer and marketer perhaps best known for its top selling product, anti-depression drug Lexapro, which sold $587 million in its most recent quarter.

Analyst Upgrades

• Applied Materials (AMAT) to overweight from neutral at Piper Jaffray.
• Air Products (APD) to buy from hold at Citigroup.
• Youku.com (YOKU) and Pinnacle West (PNW) to buy from neutral at Goldman.
• Stryker (SYK) and Zimmer (ZMH) to buy from neutral at UBS.
• Zions Bancorp (ZION) to outperform from neutral at Macquarie.
• Alnylam (ALNY) to buy from hold at Needham.
• AK Steel (AKS) to buy from hold at KeyBanc.

Our recommendations center on a collection of five stocks that we believe, as a group, will outperform the market this month. The Buyback Premium Portfolio is beating the S&P 500 by more than 65% since its inception (August 2, 2000)! This portfolio is up 54.48% since inception (August 2, 2000) vs. a decline of 10.56% in the S&P 500 over the same time frame. We hope that you are participating in these profits. For the month of January 2011, The Buyback Premium Portfolio gained 1.18% vs. a gain of 2.27% in the S&P 500.

Forest Laboratories (FRX - option chain) shares are rising today after the company reported third-quarter earnings this morning, posting a profit of $320.7 million, or $1.11 per share. Excluding one-time items, FRX earned $1.34 per share on revenue of $1.13 billion. Analysts had forecast a profit of $0.99 per share on revenue of $1.10 billion. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on FRX.

FRX opened this morning at $32.80. So far today the stock has hit a low of $31.94 and a high of $32.80. As of 12:20, FRX is trading at $32.40 up 0.96 (3.0%). The chart for FRX looks bullish and S&P gives FRX a positive 4 STARS (out of 5) buy ranking.

Analyst Upgrades

• Piper Jaffray upgraded Edwards Lifesciences (EW) to overweight from neutral and raised its target price for shares to $77 from $53 after The New England Journal of Medicine reported the company's PARTNER Trial met primary endpoints.
• UBS upgraded Endo Pharmaceuticals (ENDP) to buy from neutral and raised its price target to $36 from $25. UBS is positive on Endo's creative strategic deals and believes the switch to Opana TRF from Opana ER will be easy. Additionally, the analyst believes pipeline expectations are very low.
• BMO Capital upgraded Nvidia (NVDA) to outperform from market perform based on expectations that share loss in the core GPU business will stop, Tegra momentum and valuation. The firm raised its price target to $16 from $9.
• FirstEnergy (FE) and Allegheny Energy (AYE) were upgraded to outperform from neutral at Credit Suisse.
• Mylan (MYL) was upgraded to conviction buy from buy at Goldman. Warner
• Chilcott (WCRX) was upgraded to overweight from equal weight at Morgan Stanley.

Analyst Upgrades

• Soleil upgraded Thor Industries (THO) to buy from hold after the company said its accounting review will not lead to changes to previously taken accounting positions. The firm raised its target for shares to $45 from $28.
• Citigroup upgraded Family Dollar (FDO) to buy from hold, citing valuation and its positive view on the dollar store industry. The firm upped its target for shares to $47 from $44.
• Wells Fargo upgraded Albany Molecular (AMRI) to outperform from market perform, citing valuation and a stabilizing core business.
• Goldman Sachs (GS) upgraded to overweight from neutral at JPMorgan.
• Patterson-UTI Energy (PTEN) was upgraded to equal weight from underweight at Barclays.
• BP (BP) was raised to buy from hold at RBS.

Analyst Upgrades

• UBS upgraded UPS (UPS) and FedEx (FDX) to buy from hold based on recent weakness and leverage to a recovery. The firm raised its price target on UPS to $74 from $72 and on FedEx to $100 from $97.
• Bernstein upgraded Medicis (MRX) to outperform from market perform based on valuation and said the company has been executing well over the past few months. The firm has a $28 price target on the stock.
• Citigroup upgraded Weingarten Realty (WRI) to buy from hold, citing valuation and the company's improved balance sheet. The firm maintains a $24 price target for shares.
• Home Depot (HD) and Lowe's (LOW) were upgraded to market perform from underperform at BMO Capital.
• NextEra Energy (NEE) was upgraded to outperform from neutral at Baird.
• Nokia (NOK) was upgraded to neutral from reduce at WestLB.

Analyst Upgrades

• Bernstein upgraded Corning (GLW) to outperform from market perform based on Gorilla glass prospects and valuation. The firm raised its price target to $22 from $21.
• RBC Capital upgraded Beckman Coulter (BEC) two rating levels to outperform from underperform, citing valuation and customer checks that indicate high retention rates. The firm upped its target for shares to $65 from $55.
• Credit Suisse upgraded Canadian Pacific (CP) to outperform from underperform. The firm expects Canadian Pacific to have stronger-than-average Q2 volume growth, improved productivity and notes leverage to growth in Asia, among other reasons for the upgrade. The firm raised its target to $75 from $59.
• Freeport McMoRan (FRX) was upgraded to overweight from neutral at HSBC.
• Solera (SLH) was upgraded to strong buy from buy at Needham.
• Jefferies upgraded IPC The Hospitalist Co. (IPCM) to buy from hold.

Analyst Upgrades

• Scotia Capital upgraded Apple (AAPL) to outperform from sector perform, citing valuation, potential increased iPhone distribution and iPad upside. The firm's two-year price target is $325.
• UBS upgraded Parker-Hannifin (PH) to neutral from sell following the company's better-than-expected Q3 report.
• Piper Jaffray upgraded Arkansas Best (ABFS) to neutral from underweight after the Teamsters union announced a tentative agreement with the company. The firm has a $33 price target for shares.
• Harley-Davidson (HOG) was upgraded to market perform from underperform at Raymond James.
• Allegheny Tech (ATI) was upgraded to buy from hold at KeyBanc.
• Manhattan Associates (MANH) was upgraded to buy from hold at Benchmark.

Analyst Upgrades

• BMO Capital upgraded EOG Resources (EOG) to market perform from underperform. The firm has a $100 target on the stock.
• Morgan Joseph upgraded Glimcher Realty (GRT) to buy from neutral with a $6.50 target. The firm believes the company has solved most of its liquidity problems while its dividend yield is very attractive.
• Citigroup upgraded AmerisourceBergen (ABC) to buy from hold.
• Lincoln Electric (LECO) was upgraded to gradually accumulate from hold at Soleil.
• BMC Software (BMC) was upgraded to outperform from neutral at Credit Suisse.
• Mercer (MERC) was upgraded to outperform from market perform at Raymond James.

Analyst Upgrades

• JPMorgan upgraded Mohawk (MHK) to overweight from neutral. The firm finds shares attractive following their recent underperformance and has a positive outlook for the building products space in 2010. JPMorgan has a $53.50 price target on the stock.
• Stephens upgraded Alexander & Baldwin (ALEX) to overweight from equal weight to reflect improving volume trends and the upcoming move of the company's Transport division from Japan to Guam, which it believes will serve as a positive catalyst. Stephens raised its target price on shares to $41 from $26.
• Deutsche Bank upgraded Unum Group (UNM) to buy from hold as it believes an acceleration of growth and potential buybacks could serve as positive catalysts. The firm raised its target on shares to $26 from $25.
• News Corp. (NWS) was raised to neutral from sell at Pali Capital.
• CA Inc. (CA) was upgraded to buy from hold at Jefferies.
• Pactiv (PTV) was upgraded to buy from hold at KeyBanc.

Analyst upgrades:

• UBS upgraded Apple (NASDAQ: AAPL) to Buy from Neutral and raised its target to $265 from $170, citing higher iPhone expectations, new partnerships, and likely upward revisions to Street estimates driven by gross margins.
• Wells Fargo upgraded Comcast (NASDAQ: CMCSA) to Outperform from Market Perform. The firm views a possible deal between end General Electric's (NYSE: GE) NBC Universal positively, as it thinks NBC will provide higher-margin growth for Comcast.
• Janney Montgomery upgraded Michael Baker (AMEX: BKR) to Buy from Neutral after the company completed the sale of its Energy business. The firm raised its target on shares to $46 from $40.
• Jefferies assumed coverage of Endo Pharma (NASDAQ: ENDP) and upgraded the stock to Buy from Hold. The firm cites valuation, a strong base business, and solid cash flow for the upgrade, and has a $30 target price on shares.
• Marten Transport (NASDAQ: MRTN) was upgraded to Overweight from Equal Weight at Stephens.
• U.S. Bancorp (NYSE: USB) was upgraded to Outperform from Market Perform at Keefe Bruyette.

• Merriman upgraded Taser (NASDAQ: TASR) to Buy from Neutral as it believes current valuation levels do not reflect the company's market opportunities and that the law enforcement funding in President Obama's stimulus plan will boost sales in Q4 and FY10.
  
• Goldman upgraded Macy's (NYSE: M) to Buy from Neutral and added shares to its Conviction Buy List based on reduced balance sheet concerns and improved risk/reward. The firm also raised their target to $8.25 from $8.
  
• JP Morgan upgraded Family Dollar (NYSE: FDO) to Neutral from Underweight and raised its target to $29 from $19 following the better-than-expected Q2 report. The analyst continues to prefer Dollar Tree (NASDAQ: DLTR) and Wal-Mart (NYSE: WMT).
• Goldman removed Universal Am (NYSE: UAM) from the Conviction Sell List.
  
• McDermott (NYSE: MDR) was upgraded to Buy from Hold at Jefferies.
  
• Canadian Natural (NYSE: CNQ) was upgraded to Sector Outperformer from Sector Performer at CIBC.